Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-64.13	13.41	37.38
Graham Fair Price	70.90	62.65	36.66
PEG	90.89	0.46	0.24
Price/Book	-11.87	2.33	2.65
Price/Cash Flow	6.26	31.66	-29.80
Prices/Earnings	-63.72	6.65	18.33
Price/Sales	-49.90	6.63	13.24
Price/FCF	6.26	31.66	-29.80
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	1.49	0.80	0.79
Operating Margin	36.83	0.34	0.25
ROA	132.49	0.05	0.02
ROE	0.04	0.09	142.91
ROIC	0.04	0.09	139.49
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.07	0.19	-63.29
Dividends QOQ	-1.00	-0.33	66.87
EBIT QOQ	-0.25	1.64	546.94
EPS QOQ	0.75	0.14	-80.99
FCF QOQ	-6.86	1.91	-72.17
Revenue QOQ	-0.07	0.93	1158.70
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	755.33	418.60	-44.58
Days Sales Outstanding (DSO)	24.42	55.65	127.87
Inventory Turnover	0.12	0.22	80.44
Debt/Capitalization	0.01	0.01	-2.14
Quick Ratio	1.44	1.45	0.83
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	40.69	44.62	9.65
Cash	31.54	32.55	3.18
Capex	-1.30	-1.36	-4.56
Free Cash Flow	-3.61	3.29	-9.06
Revenue	8.13	15.68	92.90
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.06	1.96	-4.79
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-14.24	-6.03	57.68
Naive Interpretation	Member

06 - Financial Health · Weak

Rating